{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:53:33Z","timestamp":1791374013687,"version":"4.3.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009243","name":"Direction G\u00e9n\u00e9rale de l\u2019offre de Soins","doi-asserted-by":"publisher","award":["PHRC-N-20-0351"],"award-info":[{"award-number":["PHRC-N-20-0351"]}],"id":[{"id":"10.13039\/501100009243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-24-MIEM-0003"],"award-info":[{"award-number":["ANR-24-MIEM-0003"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004571","name":"Minist\u00e8re des Affaires Sociales et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","award":["101156304"],"award-info":[{"award-number":["101156304"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.idnow.2025.105135","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T21:26:53Z","timestamp":1755811613000},"page":"105135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rapid-sequence clinical research before and during a pandemic: Lessons learned and the way forward"],"prefix":"10.1016","volume":"55","author":[{"given":"Florence","family":"Ader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9lo\u00efse","family":"Aubret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Bergaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maude","family":"Bouscambert-Duchamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Circosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Couffin-Cadiergues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Danion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpha","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Faure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Fougerou-Leurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Gaymard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soizic","family":"Le Mestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Locher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auriane","family":"Merelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Peiffer-Smadja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Pellegrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ventzislava","family":"Petrov-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Wittkop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idnow.2025.105135_b0005","doi-asserted-by":"crossref","first-page":"62e70","DOI":"10.1056\/NEJMra1510062","article-title":"Master protocols to study multiple therapies, multiple diseases, or both","volume":"377","author":"Woodcock","year":"2017","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.idnow.2025.105135_b0010","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1001\/jama.2015.2316","article-title":"The platform trial: an efficient strategy for evaluating multiple treatments","volume":"313","author":"Berry","year":"2015","journal-title":"J Am Med Assoc"},{"issue":"11","key":"10.1016\/j.idnow.2025.105135_b0015","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1093\/cid\/ciaa334","article-title":"Resist the temptation of response-adaptive randomization","volume":"71","author":"Proschan","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"16","key":"10.1016\/j.idnow.2025.105135_b0020","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMc2102446","article-title":"Platform trials - beware the noncomparable control group","volume":"384","author":"Dodd","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idnow.2025.105135_b0025","doi-asserted-by":"crossref","unstructured":"Ader F and the DisCoVeRy French Trial Management Team. Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults. BMJ Open 2020;10: e041437.","DOI":"10.1136\/bmjopen-2020-041437"},{"issue":"6","key":"10.1016\/j.idnow.2025.105135_b0030","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"WHO solidarity trial consortium. Repurposed antiviral drugs for Covid-19 - interim WHO solidarity trial results","volume":"384","author":"Pan","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idnow.2025.105135_b0035","unstructured":"WHO Solidarity Trial Consortium. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses. Lancet 2022 May 21;399(10339):1941-1953."},{"key":"10.1016\/j.idnow.2025.105135_b0040","doi-asserted-by":"crossref","unstructured":"EU-Response investigators group, Diallo A, Tr\u00f8seid M, Simensen VC, Boston A, Demotes J, et al. Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group. Clin Microbiol Infect 2022 Jan;28(1):1-5.","DOI":"10.1016\/j.cmi.2021.10.011"},{"key":"10.1016\/j.idnow.2025.105135_b0045","unstructured":"Website that brings together structured, cleaned data from clinical trial registries on studies of COVID-19 and track the availability of their results. Available at https:\/\/covid19.trialstracker.net\/ (Accessed May 11, 2025)."},{"key":"10.1016\/j.idnow.2025.105135_b0050","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/d41573-021-00037-3","article-title":"Trends in COVID-19 therapeutic clinical trials","volume":"20","author":"Bugin","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"9912","key":"10.1016\/j.idnow.2025.105135_b0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(13)62229-1","article-title":"How to increase value and reduce waste when research priorities are set","volume":"383","author":"Chalmers","year":"2014","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.idnow.2025.105135_b0060","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/medethics-2016-103680","article-title":"When clinical trials compete: prioritising study recruitment","volume":"43","author":"Gelinas","year":"2017","journal-title":"J Med Ethics"},{"issue":"26","key":"10.1016\/j.idnow.2025.105135_b0065","article-title":"A Comprehensive Analysis of COVID-19 misinformation, public health impacts, and communication strategies: scoping review","volume":"21","author":"Kisa","year":"2024","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.idnow.2025.105135_b0070","unstructured":"WHO. WHO policy brief: COVID-19 infodemic management. (2022). Available at: https:\/\/www.who.int\/health-topics\/infodemic#tab=tab_1 (Accessed May 11, 2025)."},{"issue":"4","key":"10.1016\/j.idnow.2025.105135_b0075","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1473-3099(20)30944-0","article-title":"Cyber harassment of female scientists will not be the new norm","volume":"21","author":"Samer","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.idnow.2025.105135_b0080","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/S1473-3099(20)30866-5","article-title":"Hydroxychloroquine and COVID-19: a tale of populism and obscurantism","volume":"21","author":"Peiffer-Smadja","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idnow.2025.105135_b0085","unstructured":"National Institute for Health Research. UK\u2019s top doctors urge recruitment of COVID-19 patients for vital scientific research. 2020. https:\/\/www.nihr.ac.uk\/news\/uks-to-doctors-urge-recruitment-of-covid-19-patients-for-vital-scientific-research\/24591 (Accessed May 11, 2025)."},{"key":"10.1016\/j.idnow.2025.105135_b0090","unstructured":"Oxford University News Release: Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 https:\/\/www.recoverytrial.net\/files\/recovery_dexamethasone_statement_160620_v2final.pdf (Accessed May 11, 2025)."},{"key":"10.1016\/j.idnow.2025.105135_b0095","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19-preliminary report. N Engl J Med 2021; 384: 693-704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"10.1016\/j.idnow.2025.105135_b0100","unstructured":"The Writing Committee for the REMAP-CAP Investigators. Effect of Hydrocortisone on Mortality and Organ Support in Patients with Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA 2020;324(13):1317-1329."},{"key":"10.1016\/j.idnow.2025.105135_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2023.107267","article-title":"Ensuring quality control in a COVID-19 clinical trial during the pandemic: the experience of the Inserm C20-15 DisCoVeRy study","volume":"131","author":"Fougerou-Leurent","year":"2023","journal-title":"Contemp Clin Trials"},{"issue":"3","key":"10.1016\/j.idnow.2025.105135_b0110","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1072","article-title":"DisCoVeRy Safety Working group. Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial","volume":"11","author":"Mercier","year":"2023","journal-title":"Pharmacol Res Perspect"},{"issue":"10","key":"10.1016\/j.idnow.2025.105135_b0115","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/pds.4932","article-title":"Trial designs using real-world data: the changing landscape of the regulatory approval process","volume":"29","author":"Baumfeld Andre","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"350","key":"10.1016\/j.idnow.2025.105135_b0120","article-title":"The PRECIS-2 tool: designing trials that are fit for purpose","volume":"8","author":"Loudon","year":"2015","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.idnow.2025.105135_b0125","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1510059","article-title":"Pragmatic trials","volume":"375","author":"Ford","year":"2016","journal-title":"N Engl J Med"},{"issue":"340","key":"10.1016\/j.idnow.2025.105135_b0130","article-title":"Rethinking pragmatic randomised controlled trials: introducing the \u201ccohort multiple randomised controlled trial\u201d design","volume":"19","author":"Relton","year":"2010","journal-title":"BMJ"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991925001149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991925001149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:18:10Z","timestamp":1791371890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991925001149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2666991925001149"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2025.105135","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid-sequence clinical research before and during a pandemic: Lessons learned and the way forward","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2025.105135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105135"}}